Abstract:Abstract Introduction Fusarium species are ubiquitous in the environment and can cause opportunistic infections in burn-injured patients. Patients with larger burns, prolonged lengths of stay, concomitant antimicrobial use and invasive lines are at higher risk for Fusarium infections. Little data exists on clinical characteristics and in vivo antifungal susceptibilities in burn-injured patients. Methods All positive Fusarium species cultures were retrospectively identified between November 2017 to June 2023 at a regional burn center. Demographic, clinical and microbiologic susceptibility data was collected from the electronic medication record. Descriptive statistics were used to describe the cohort. Results A total of 18 patients had positive Fusarium wound cultures during the study period. The average age was 38.4 ± 11.9 years. The average %TBSA was 54.5 ± 23.4 % and R-Baux score of 92.9 ± 29.3. The most common mechanism of injury was thermal burn (17 patients, 94%). This cohort experienced prolonged ICU (68.9 ± 31.9 days) and hospital (73.6 ± 38.2 days) lengths of stay. The average time from burn injury to positive Fusarium cultures was 19.6 ± 9.0 days. Mechanical ventilation was prolonged (46.1 ± 23.3 days). The average central line duration prior to Fusarium infection was 9.8 ± 10.2 days. Susceptibility data was obtained for voriconazole in 15 patients and for amphotericin in 14 patients. For voriconazole, 5/15 tested isolates had an MIC of 4, 1/15 had an MIC of 8, and 9/15 (60%) isolates returned with MIC ≥ 16. A majority (13/14, 93%) of the MICs tested for amphotericin were ≤ 1. Patients were taken to the OR for source control in all cases. Ten of 18 patients with Fusarium positive infections survived to hospital discharge (55%). The most common cause of death was multi-system organ failure and sepsis (88%). Recorded adverse drug events possibly due to voriconazole and posaconazole included transaminitis (4 cases), QTc prolongation (1 case), and hallucinations (1 case). Amphotericin was suspected of contributing to an acute kidney injury in 1 case. Conclusions This case series reports the clinical characteristics and susceptibility data on Fusarium isolates in a burn-injured population. This cohort was critically ill based on the %TBSA, R-Baux score, and high rate of mechanical ventilation. The MIC results obtained for voriconazole demonstrated a majority of isolates with relatively high MIC values ≥ 16. A majority of the MICs for amphotericin were < 1. It is important to note that no established breakpoints exist for Fusarium species and clinical outcomes are dependent on a variety of factors beyond the susceptibility data. Applicability of Research to Practice Empiric double coverage with voriconazole and amphotericin or amphotericin monotherapy should be considered when Fusarium is a suspected primary pathogen.

Epidemiology, Molecular Mycology, and Environmental Sources of Fusarium Infection in Patients with Cancer

Invasive fusariosis in patients with hematologic malignancies at a cancer center: 1998–2009

Epidemiology and Clinical Outcomes of Fusobacterium Infections: A Six-Year Retrospective Study

Prevalence and pattern of isolated fungi from bronchoalveolar lavage among patients with lung cancer: a prospective cross-sectional study

505 Fusarium Isolates in Burn-injured Patients: Clinical Characteristics and Susceptibility Patterns

European Confederation of Medical Mycology (ECMM) epidemiological survey on invasive infections due to Fusarium species in Europe

Aspergillosis caused by non-fumigatus Aspergillus species: risk factors and in vitro susceptibility compared with Aspergillus fumigatus

Multicenter Retrospective Study of Invasive Fusariosis in Intensive Care Units, France

Aspergillus terreus: an emerging amphotericin B–resistant opportunistic mold in patients with hematologic malignancies

Skin lesions associated with Fusarium infection

The epidemiology of Candida glabrata and Candida albicans fungemia in immunocompromised patients with cancer

Invasive fusariosis in acute leukaemia patients-An outbreak in the haematology ward

Clinical characteristics and antimicrobial susceptibility of Fusobacterium species isolated over 10 years at a Japanese university hospital

Epidemiology and Clinical Features of Invasive Fungal Infection in a US Health Care Network

Unveiling the Hidden Links: Periodontal Disease, Fusobacterium Nucleatum, and Cancers

[Epidemiologic Study on Patients with Invasive Fungal Infections].

Fungemia: A Retrospective Clinical Analysis of 17 Patients

Caspofungin-non-susceptible Candida isolates in cancer patients

P210 Fungal isolates of the respiratory tract in symptomatic patients hospitalized in pulmonary units: A mycological and molecular epidemiologic study

Fusariosis in Mexico: A 10-year retrospective series

Clinical Features and Outcomes of Invasive Fusariosis: A Case Series in a Single Center with Literature Review